Vimab Group AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was SEK 0.002 million compared to SEK 59.33 million a year ago. Net loss was SEK 0.946 million compared to net income of SEK 0.679 million a year ago. Basic loss per share from continuing operations was SEK 0.3 compared to basic earnings per share from continuing operations of SEK 0.3 a year ago.
For the six months, sales was SEK 0.043 million compared to SEK 107.38 million a year ago. Revenue was SEK 0.045 million compared to SEK 107.63 million a year ago. Net loss was SEK 3.18 million compared to net income of SEK 4.12 million a year ago. Basic loss per share from continuing operations was SEK 1.2 compared to basic earnings per share from continuing operations of SEK 1.5 a year ago.